Company code: Zhejiang Gongdong Medical Technology Co.Ltd(605369) company abbreviation: Zhejiang Gongdong Medical Technology Co.Ltd(605369) Zhejiang Gongdong Medical Technology Co.Ltd(605369)
Annual report for 2021
Important tips
1、 The board of directors, board of supervisors, directors, supervisors and senior managers of the company guarantee the authenticity, accuracy and integrity of the contents of the annual report, and there are no false records, misleading statements or major omissions, and bear individual and joint legal liabilities. 2、 All directors of the company attended the board meeting. 3、 Tianjian Certified Public Accountants (special general partnership) issued a standard unqualified audit report for the company. 4、 Shi Huiyong, the person in charge of the company, pan Lei, the person in charge of accounting, and Cheng Juwen, the person in charge of the accounting organization (Accounting Supervisor), declare that they guarantee the authenticity, accuracy and completeness of the financial report in the annual report. 5、 The profit distribution plan or the plan of converting accumulation fund into share capital in the reporting period adopted by the resolution of the board of directors
The company's profit distribution plan for 2021 is as follows:
1. The company plans to distribute a cash dividend of 13.80 yuan (including tax) to all shareholders for every 10 shares. As of the date of disclosure of this profit distribution plan, the total share capital of the company is 112627120 shares. Based on this calculation, the total cash dividend to be distributed is 15542542560 yuan (including tax), accounting for 49.98% of the net profit attributable to the shareholders of the parent company in the consolidated statement, and the remaining undistributed profit is carried forward to the next year.
2. If the total share capital of the company changes between the date of disclosure of this profit distribution plan and the date of equity distribution registration, the company plans to maintain the distribution proportion per share unchanged and adjust the total distribution accordingly.
3. This profit distribution plan needs to be submitted to the general meeting of shareholders of the company for deliberation. 6、 Risk statement of forward-looking statements
√ applicable □ not applicable
The business plan, development strategy, future plan and other forward-looking statements involved in this report do not constitute the company's substantive commitment to investors. Investors and relevant persons should maintain sufficient risk awareness and understand the differences between plans, forecasts and commitments. 7、 Is there any non operating occupation of funds by the controlling shareholders and their related parties
VIII. Whether there is any external guarantee in violation of the specified decision-making procedures
no
9、 Whether more than half of the directors cannot guarantee the authenticity, accuracy and completeness of the annual report disclosed by the company
X. major risk warning
The company has described the possible relevant risks in this report. Please pay attention to them and refer to (IV) "possible risks" in Section III "management discussion and analysis" VI "discussion and Analysis on the company's future development" of this report and "risks related to financial instruments" in section X "financial report" of this report. 11、 Other
□ applicable √ not applicable
catalogue
Section 1 interpretation four
Section 2 company profile and main financial indicators Section III Management Discussion and Analysis Section IV corporate governance Section V environmental and social responsibility 69 section VI important matters Section VII share changes and shareholders 87 Section VIII preferred shares 96 section IX information related to bonds 97 section x financial report ninety-eight
(I) financial statements containing the signatures and seals of the person in charge of the company, the person in charge of accounting work and the person in charge of the accounting organization (the person in charge of Accounting)
The catalogue of documents for future reference (II) contains the original audit report sealed by the accounting firm and signed and sealed by the certified public accountant
(III) originals of all company documents and announcements publicly disclosed during the reporting period
Section I interpretation
1、 Interpretation
In this report, unless the context otherwise requires, the following words have the following meanings: Interpretation of common words
Zhejiang Gongdong Medical Technology Co.Ltd(605369) , the company and the company refer to Zhejiang Gongdong Medical Technology Co.Ltd(605369)
Jinchi investment refers to Taizhou Jinchi investment management partnership (limited partnership)
Maide mould refers to Zhejiang Maide medical mould Co., Ltd
GD medical means GD medical, Inc
CSRC and CSRC refer to the China Securities Regulatory Commission
Shanghai Stock Exchange and stock exchange refer to Shanghai Stock Exchange
State health and Family Planning Commission of the people's Republic of China. In March 2018, the national health and Family Planning Commission and the National Health Commission indicated that, according to the institutional reform plan of the State Council approved at the first session of the 13th National People's Congress, the responsibilities of the national health and Family Planning Commission were integrated and the National Health Commission of the people's Republic of China was established
The third meeting refers to the general meeting of shareholders, the board of directors and the board of supervisors of the company
Company Law refers to the company law of the people's Republic of China
Securities Law refers to the securities law of the people's Republic of China
The articles of association refers to the Zhejiang Gongdong Medical Technology Co.Ltd(605369) articles of association
Thermo Fisher means Thermo Fisher Scientific, Inc., a company listed on the New York Stock Exchange (TMO. N)
McKesson means McKesson Corporation, a company listed on the New York Stock Exchange
（MCK.N）
As one means as one corporation, a company listed on the Tokyo Stock Exchange (7476. T)
Cardinal means Cardinal Health, Inc., a company listed on the New York Stock Exchange
（CAH.N）
Henry Schein means Henry Schein Inc., a company listed on the Nasdaq Stock Exchange
（HSIC.O）
MEDLINE refers to MEDLINE industries, Inc., a world-famous manufacturer and distributor of medical products
IDEXX means IDEXX laboratories, Inc., a company listed on the Nasdaq Stock Exchange
（IDXX.O）
Zhejiang Youlai refers to Zhejiang Youlai Medical Instrument Co., Ltd
Zhejiang Hengda refers to Zhejiang Hengda Medical Instrument Co., Ltd
Sponsor refers to Zhongtai Securities Co.Ltd(600918)
Certified Public Accountants and Tianjian certified public accountants refer to Tianjian Certified Public Accountants (special general partnership)
In vitro diagnosis (IVD) refers to the products and services outside the human body to obtain clinical diagnosis information by detecting human samples (blood, body fluid, tissue, etc.) through in vitro diagnosis and IVD, so as to judge diseases or body functions
Epidemic prevention products refer to the introduction of medical isolation surface in the early stage of covid-19 outbreak in the second quarter of 2020
Cover, virus sampling tube and other new anti epidemic products
Polystyrene (PS) is a kind of polymer material, which is widely used in the field of disposable medical consumables
Polypropylene (PP) refers to a kind of polymer material, which can be used in the field of disposable medical consumables
Polyethylene (PE) refers to a kind of polymer material, which can be used in the field of disposable medical consumables
Shares, A-share index RMB ordinary shares with a par value of 1 yuan
RMB and RMB refer to RMB and RMB
Period from December 31, 2021 to December 31, 2021
Unless otherwise specified, all values in this report retain 2 decimal places. If the sum of the itemized values is inconsistent with the mantissa of the total, it is caused by rounding.
Section II Company Profile and main financial indicators
1、 Company information
Chinese name of the company Zhejiang Gongdong Medical Technology Co.Ltd(605369)
Chinese abbreviation of the company Zhejiang Gongdong Medical Technology Co.Ltd(605369)
The foreign language name of the company is Zhejiang Gongdong Medical Technology Co., Ltd
The abbreviation of the company's foreign name is Gongdong medical
The legal representative of the company is Shi Huiyong
2、 Contact person and contact information
Secretary of the board of directors and securities affairs representative
Name: Jin Shiwei, Wang Jiamin
Contact address: No. 10, Beiyuan Avenue, Huangyan District, Taizhou City, Zhejiang Province No. 10, Beiyuan Avenue, Huangyan District, Taizhou City, Zhejiang Province
Tel: 057684081101
Fax: 057684050789
E-mail [email protected]. [email protected].
3、 Basic information
Registered address: No. 10, Beiyuan Avenue, Huangyan District, Taizhou City, Zhejiang Province
Since the establishment of Zhejiang Zhejiang Gongdong Medical Technology Co.Ltd(605369) Technology Co., Ltd., the predecessor of the company, on August 17, 2009, the actual registered address of the company has not changed. The address has adopted the "Beicheng District, West Industrial Park, Huangyan Economic Development Zone, Taizhou City" in the same historical stage without the historical change of the registered address of the company "No. 10 Beiyuan Avenue, Huangyan District, Taizhou City" and other different forms of expression
Office address: No. 10, Beiyuan Avenue, Huangyan District, Taizhou City, Zhejiang Province
The postal code of the company's office address is 318020
Company website: www.gongdong.com com.
E-mail [email protected].
4、 Information disclosure and preparation location
The media name of the annual report disclosed by the company and the address of the website China Securities News, Shanghai Securities News and Securities Times Securities Daily
The company's annual report is disclosed on the website of the stock exchange www.sse.com com. cn.
